EA201270116A1 - Применение лекарственной формы для наружного нанесения, содержащей хитозан - Google Patents

Применение лекарственной формы для наружного нанесения, содержащей хитозан

Info

Publication number
EA201270116A1
EA201270116A1 EA201270116A EA201270116A EA201270116A1 EA 201270116 A1 EA201270116 A1 EA 201270116A1 EA 201270116 A EA201270116 A EA 201270116A EA 201270116 A EA201270116 A EA 201270116A EA 201270116 A1 EA201270116 A1 EA 201270116A1
Authority
EA
Eurasian Patent Office
Prior art keywords
application
nail
chitosan
containing chitosan
medical form
Prior art date
Application number
EA201270116A
Other languages
English (en)
Russian (ru)
Inventor
Федерико Маилланд
Original Assignee
Полихем С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38345983&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201270116(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Полихем С.А. filed Critical Полихем С.А.
Publication of EA201270116A1 publication Critical patent/EA201270116A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
EA201270116A 2007-02-14 2008-02-07 Применение лекарственной формы для наружного нанесения, содержащей хитозан EA201270116A1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07102335A EP1958638A1 (en) 2007-02-14 2007-02-14 Use of chitosans to increase nail growth rate

Publications (1)

Publication Number Publication Date
EA201270116A1 true EA201270116A1 (ru) 2012-06-29

Family

ID=38345983

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201270116A EA201270116A1 (ru) 2007-02-14 2008-02-07 Применение лекарственной формы для наружного нанесения, содержащей хитозан
EA200901093A EA018390B1 (ru) 2007-02-14 2008-02-07 Применение хитозана, аминополисахарида хитозана и/или его физиологически приемлемой соли для ускорения роста ногтей

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA200901093A EA018390B1 (ru) 2007-02-14 2008-02-07 Применение хитозана, аминополисахарида хитозана и/или его физиологически приемлемой соли для ускорения роста ногтей

Country Status (31)

Country Link
US (3) US8680074B2 (enExample)
EP (3) EP1958638A1 (enExample)
JP (3) JP5426401B2 (enExample)
KR (2) KR101131015B1 (enExample)
CN (2) CN101663039B (enExample)
AR (1) AR065316A1 (enExample)
AT (1) ATE522221T1 (enExample)
AU (1) AU2008214693B2 (enExample)
BR (1) BRPI0807595A2 (enExample)
CA (1) CA2677715C (enExample)
CL (2) CL2008000444A1 (enExample)
CO (1) CO6230979A2 (enExample)
CY (2) CY1112058T1 (enExample)
DK (2) DK2117564T3 (enExample)
EA (2) EA201270116A1 (enExample)
ES (2) ES2369116T3 (enExample)
HR (2) HRP20110667T1 (enExample)
IL (1) IL200269A (enExample)
MA (1) MA31236B1 (enExample)
ME (1) ME00830B (enExample)
MX (1) MX2009008686A (enExample)
MY (2) MY154499A (enExample)
NZ (1) NZ578896A (enExample)
PH (1) PH12014500274A1 (enExample)
PL (2) PL2117564T3 (enExample)
PT (2) PT2377541E (enExample)
RS (2) RS52031B (enExample)
SI (2) SI2117564T1 (enExample)
UA (1) UA100011C2 (enExample)
WO (1) WO2008098869A2 (enExample)
ZA (1) ZA200905443B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10201490B2 (en) 2007-02-14 2019-02-12 Polichem Sa Use of chitosans for the treatment of nail inflammatory diseases
WO2010109423A1 (en) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi A medicinal antifungal and steroids cream comprising chitosan and a process to make it
CN103987370A (zh) * 2011-10-05 2014-08-13 阿勒根公司 用于增进指甲健康的组合物
PT2793946T (pt) * 2011-12-20 2019-05-08 Urgo Rech Innovation Et Developpement Composição tópica filmogénica e uso da mesma para tratar ou prevenir a onicofagia
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EP2845597A1 (en) * 2013-09-10 2015-03-11 Polichem S.A. Hydroxypropyl chitosan for the treatment of onychomycosis
EP2910245A1 (en) * 2014-02-21 2015-08-26 Polichem SA Topical antifungal composition for treating onychomycosis
CN109893472A (zh) * 2019-04-09 2019-06-18 涿州皓原箔业有限公司 一种环保无毒水性卸甲液及其制备方法
ES2834732B2 (es) * 2019-12-17 2022-03-24 Univ Valladolid Solucion acuosa que comprende un complejo de inclusion, metodo de obtencion y su uso para aplicacion en cultivos y la mejora de su rendimiento
CN111388416B (zh) * 2020-02-26 2022-03-08 浙江康德药业集团股份有限公司 一种盐酸利多卡因胶浆剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3541305A1 (de) 1985-11-22 1987-05-27 Wella Ag Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung
DE3723811A1 (de) * 1987-07-18 1989-01-26 Wella Ag Nagellack auf der basis von o-benzyl-n-hydroxyalkylchitosanen sowie neue o-benzyl-n-hydroxyalkylderivate des chitosans
CA2008775C (en) 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
DE69310339T2 (de) 1993-02-19 1997-08-21 Philippe Djian Präparate, die Corneozyt Proteine enthalten
FR2718637A1 (fr) * 1994-04-15 1995-10-20 Oreal Composition cosmétique à appliquer sur l'ongle.
RU2108114C1 (ru) * 1996-12-27 1998-04-10 Товарищество с ограниченной ответственностью Научно-производственное предприятие "Эрлон", Лтд. Биологическая композиция для лечения ран "коллахит"
ITTO980264A1 (it) 1998-03-26 1999-09-26 Silvio Rossi Applicazione di un estratto basico non quaternario della peschiera fuchsiaefolia ad attivita' antimalarica
US6391334B1 (en) * 1999-10-25 2002-05-21 Amway Corporation Barrier-forming composition
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
EP1455802B1 (en) * 2001-12-14 2008-10-15 Dnp Canada Inc. Uses of chitosan oligosaccharides
EP1440683A1 (de) * 2003-01-23 2004-07-28 Cognis France S.A. Verwendung von Oligoglucosaminen in kosmetischen oder dermatologischen Zubereitungen
EP1491202A1 (en) * 2003-06-23 2004-12-29 Polichem S.A. Nail restructuring compositions for topical application
JP3881992B2 (ja) 2004-07-30 2007-02-14 シャープ株式会社 受信装置、受信プログラム、および受信プログラムを記録した記録媒体
WO2006111426A1 (en) * 2005-04-19 2006-10-26 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
DE102006049585A1 (de) * 2006-10-22 2008-04-24 Susilo, Rudy, Dr. Nagellack für kosmetische und medizinische Anwendungen

Also Published As

Publication number Publication date
PT2377541E (pt) 2013-11-21
RS52031B (sr) 2012-04-30
CN102988405A (zh) 2013-03-27
US20140147401A1 (en) 2014-05-29
US20100152133A1 (en) 2010-06-17
ME00830B (me) 2012-03-20
KR20110075043A (ko) 2011-07-05
KR101323762B1 (ko) 2013-11-01
ZA200905443B (en) 2010-10-27
EP2377541B1 (en) 2013-10-23
JP2015221823A (ja) 2015-12-10
BRPI0807595A2 (pt) 2014-07-22
JP6045663B2 (ja) 2016-12-14
EA018390B1 (ru) 2013-07-30
EP1958638A1 (en) 2008-08-20
IL200269A0 (en) 2010-04-29
WO2008098869A3 (en) 2008-10-09
EP2117564A2 (en) 2009-11-18
AU2008214693B2 (en) 2013-05-02
JP2013213048A (ja) 2013-10-17
DK2377541T3 (da) 2013-11-11
AU2008214693A2 (en) 2009-09-10
HRP20131175T1 (hr) 2014-01-17
PL2117564T3 (pl) 2012-03-30
MA31236B1 (fr) 2010-03-01
UA100011C2 (ru) 2012-11-12
MX2009008686A (es) 2009-08-21
RS53143B (sr) 2014-06-30
JP5426401B2 (ja) 2014-02-26
CN101663039A (zh) 2010-03-03
NZ578896A (en) 2012-02-24
AR065316A1 (es) 2009-05-27
US8680074B2 (en) 2014-03-25
DK2117564T3 (da) 2011-10-17
HRP20110667T1 (hr) 2011-10-31
SI2117564T1 (sl) 2011-12-30
CA2677715C (en) 2014-10-14
WO2008098869A2 (en) 2008-08-21
US9173827B2 (en) 2015-11-03
KR101131015B1 (ko) 2012-03-29
PL2377541T3 (pl) 2014-04-30
KR20090121312A (ko) 2009-11-25
MY163297A (en) 2017-09-15
IL200269A (en) 2015-10-29
EA200901093A1 (ru) 2010-02-26
HK1133189A1 (en) 2010-03-19
EP2377541A1 (en) 2011-10-19
CO6230979A2 (es) 2010-12-20
PT2117564E (pt) 2011-10-17
CY1112058T1 (el) 2015-11-04
PH12014500274A1 (en) 2016-06-06
MY154499A (en) 2015-06-30
CN101663039B (zh) 2013-08-07
ATE522221T1 (de) 2011-09-15
ES2369116T3 (es) 2011-11-25
CY1115136T1 (el) 2016-12-14
CL2008000444A1 (es) 2008-08-22
CL2013002052A1 (es) 2014-02-21
US20160015620A1 (en) 2016-01-21
EP2117564B1 (en) 2011-08-31
CA2677715A1 (en) 2008-08-21
SI2377541T1 (sl) 2014-01-31
JP2010518138A (ja) 2010-05-27
AU2008214693A1 (en) 2008-08-21
ES2436647T3 (es) 2014-01-03

Similar Documents

Publication Publication Date Title
EA201270116A1 (ru) Применение лекарственной формы для наружного нанесения, содержащей хитозан
MX2009013970A (es) Gel de fibrina para la liberacion controlada del factor de crecimiento derivado de plaqueta (pdgf) y sus usos.
MY155649A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
DE602006018961D1 (de) KRISTALLINE FORMEN VON 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZOL, ZUBEREITUNGSVERFAHREN DAFÜR UND DESSEN VERWENDUNG ZUR ARZNEIMITTELHERSTELLUNG
EA201001639A1 (ru) Композиции и способы их получения и применения
MX369385B (es) Productos para cicatrizar heridas tisulares.
WO2010018217A3 (en) Purin derivatives for use in the treatment of fab-related diseases
WO2010071826A3 (en) Methods for treating osteoclast-related disease, compounds and compositions thereof
MX2010010505A (es) Imidazoquinolinas y derivados de pirimidina como moduladores potentes de los procesos angiogenicos impulsados por el factor de crecimiento endotelial vascular (vegf).
WO2010016683A3 (ko) 탈모의 예방, 치료, 또는 육모용 조성물
BR112014011981A2 (pt) formulações farmacêuticas
WO2009009759A3 (en) Yersinia pestis antigens, vaccine compositions, and related methods
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
EA201291167A1 (ru) Замещенные гетероциклилбензилпиразолы и их применение
CY1115961T1 (el) Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate)
NO20076405L (no) Anvendelse av 24-nor-UDCA
WO2010135521A3 (en) Compositions and methods for the therapy and diagnosis of influenza
UA113749C2 (xx) Композиція для назального застосування з покращеною стабільністю
PH12017501444A1 (en) (2r,4r)-5-(5`-chloro-2`-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
IN2014DN09240A (enExample)
WO2007076091A3 (en) Treatment of viral infections using a tissue factor inhibitor
WO2012004588A3 (en) Therapeutic agents 976
ATE496899T1 (de) Tetrahydro- und dihydrochinazolinone
WO2008130321A3 (en) Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain
WO2007144889A3 (en) Treatment of neurofibromatosis